SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000067
Filing Date
2021-06-17
Accepted
2021-06-17 08:13:34
Documents
3
Period of Report
2021-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx61721.htm 8-K 38023
2 EX-99.1 ex991-8xkx61721.htm EX-99.1 23671
3 phasebio2020logoa.jpg GRAPHIC 27705
  Complete submission text file 0001169245-21-000067.txt   101305
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 211023395
SIC: 2834 Pharmaceutical Preparations